Suntheanine.

Caffeine blocks adenosine receptors to raise arousal while theanine raises alpha-band cortical activity and modulates glutamate signalling. The pairing is the archetypal calm-alertness combination.

The anhydrous form delivers the same adenosine receptor antagonism on a fast curve, and theanine smooths the accompanying jitteriness. Standard ratio practice sits near 2 parts theanine to 1 part caffeine.

Suntheanine is a branded, enzymatically produced pure L-isomer of theanine. Dosing both counts as one ingredient, not two.

Theanine and the catechins occur together in Camellia sinensis and are consumed together in brewed tea. Recombining them reproduces the leaf's own balance alongside its caffeine.

Shade-grown matcha is unusually high in theanine relative to other teas, which is why its caffeine reads smoother. Added theanine extends the same balance.

Theanine is a structural analogue of glutamate and shifts excitatory to inhibitory balance centrally, while GABA acts at inhibitory receptors mostly at the periphery and gut. The two are formulated together for overlapping calm signalling.

Magnesium sits in the NMDA receptor channel as a voltage-dependent block and the glycine carrier is itself an inhibitory transmitter. Both damp excitatory signalling from an angle theanine does not cover.

Glycine acts at its own inhibitory receptor and lowers core temperature ahead of sleep onset. Theanine contributes a separate alpha-wave relaxation route rather than duplicating it.

Melatonin carries the circadian timing signal while theanine lowers pre-sleep mental arousal. Combining a timing cue with an arousal cue is standard evening formulation practice.

Tyrosine feeds dopamine and noradrenaline synthesis under demanding conditions, and theanine tempers the accompanying edge. The pair is common in focus formulas built around caffeine.

Theobromine gives a slower, gentler adenosine antagonism than caffeine, and theanine adds the relaxation arm. All three occur together in cocoa and tea style stacks.

Theanine is gamma-glutamylethylamide, structurally a glutamine analogue, and it is carried across the intestinal wall and the blood brain barrier by the same L-type amino acid transporters that handle large neutral amino acids. A large concurrent dose of competing amino acids shares that transporter capacity. Taking theanine away from a heavy protein or free amino acid load is ordinary practice for this reason.

Leucine is a preferred substrate of the LAT1 transporter, the same carrier theanine uses to reach the brain. Dosing them together means they share a finite number of transport sites. This is a timing consideration rather than a reason to avoid either.

Glycine is itself an inhibitory neurotransmitter at glycine receptors and at the strychnine-insensitive site on NMDA receptors, and it lowers core temperature before sleep. Theanine acts through a different set of mechanisms including modest glutamate receptor antagonism and increased alpha-band cortical activity. The two are commonly stacked for evening formulas and their calming effects add rather than duplicate.

Magnesium sits in the NMDA receptor channel as a voltage-dependent block, damping excitatory glutamatergic signalling, and it is a cofactor for hundreds of enzymes including those of neurotransmitter synthesis. Theanine has its own weak antagonist activity at ionotropic glutamate receptors. Both converge on the same excitatory system from different angles.

Glutamate decarboxylase, the enzyme that makes GABA from glutamate, requires pyridoxal-5-phosphate. Theanine is metabolised to glutamate and ethylamine in the gut and kidney, feeding the substrate side of that reaction. B6 status therefore sits underneath the conversion of any glutamate load into inhibitory signalling.

Tryptophan is the precursor for serotonin and, further downstream, melatonin, and it competes with the large neutral amino acids for the same brain transporter that carries theanine. Theanine does not supply a monoamine precursor, so the two contribute different things to an evening formula. The transporter they share means dose timing matters when both are present.

5-HTP bypasses the rate-limiting tryptophan hydroxylase step and is decarboxylated directly to serotonin. Theanine works on cortical activity and glutamatergic tone rather than on monoamine supply, so the two are complementary rather than overlapping. Peripheral decarboxylation of 5-HTP is why it is usually kept to modest amounts.

Apigenin is a flavone with documented binding at the benzodiazepine site of the GABA-A receptor, a distinctly different site of action from theanine's. Both appear in evening formulas for that reason. The combined calming effect is additive and should be counted as such when a person is also taking anything else sedating.

Apigenin is a flavone with documented binding at the benzodiazepine site of the GABA-A receptor, a distinctly different site of action from theanine's. Both appear in evening formulas for that reason. The calming contributions may add rather than duplicate, so total sedating load is what to count when a person is taking anything else of that kind.

Melissa officinalis contains rosmarinic acid, which inhibits GABA transaminase and so slows GABA breakdown. That is a different lever from anything theanine does. The pairing appears frequently in calm-focus formulas and the two effects would be expected to add, which has not been measured as a combination.

Passiflora extracts contain flavonoids reported to modulate GABA-A signalling, and the botanical is a long-standing evening ingredient. Theanine contributes cortical alpha activity rather than receptor modulation at that site. Additive calm is the expected result and total sedating load is what to watch.

Valerian constituents including valerenic acid modulate GABA-A receptor subunits and inhibit GABA reuptake. Theanine acts elsewhere, so the pairing brings two distinct calming mechanisms into one formula. Anyone already taking something sedating should count the combination rather than each item alone.

Honokiol and magnolol from magnolia bark are positive modulators at GABA-A receptors in preclinical work. Theanine reaches a calm state without that receptor. The two are stacked in evening formulas and their effects would be expected to add, on preclinical grounds rather than a measured pairing.

Withanolides from ashwagandha are described as acting on hypothalamic-pituitary-adrenal axis signalling and cortisol dynamics over weeks of use. Theanine works acutely on cortical activity within an hour or two. The two operate on different timescales, which is why they are often combined rather than substituted.

Rhodiola is used for a stimulating rather than sedating profile, with rosavins and salidroside affecting monoamine turnover. Theanine tends to smooth the edge off stimulation without adding sedation. The pairing is a daytime construction and it pulls in two directions by design.

Taurine is a weak agonist at GABA-A and glycine receptors and acts as an osmolyte and membrane stabiliser in neural tissue. Theanine does not bind those receptors meaningfully. Both appear in calm-focus formulas on separate mechanistic grounds.

Alpha-GPC delivers choline for acetylcholine synthesis, supporting the cholinergic side of attention. Theanine contributes to cortical alpha activity rather than to any transmitter pool. Combining them addresses two independent parts of a focus formula.

Citicoline supplies both choline for acetylcholine and cytidine that converts to uridine for membrane phospholipid synthesis. Theanine adds nothing to either pool and works through cortical activity instead. The pairing is complementary rather than overlapping.

Bacosides are studied over multi-week courses with effects reported on memory acquisition measures, a slow-building profile. Theanine is an acute-acting ingredient. Formulas that combine them are pairing a same-day effect with a cumulative one.

Phosphatidylserine is a membrane phospholipid concentrated in neural tissue and has been studied for cortisol response to physical stress. Theanine acts on cortical rhythm rather than on membrane composition. The two are combined on separate rationales and no combination outcome is established.

Inositol is the backbone of the phosphatidylinositol second messenger system that sits downstream of several neurotransmitter receptors. Theanine does not act on that system directly. The pairing is common in calm formulas and the mechanistic overlap is thin, so it should be read as formulation convention.